Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-75
SponsorShanghai Institute of Acupuncture, Moxibustion and Meridian
About this trial
The aim of this study was to further improve the clinical efficacy of acupuncture in delaying the clinical recurrence of CD and to explore the efficacy mechanism of acupuncture efficacy enhancement.
Eligibility criteria
Qualifiers
patients with clinical diagnosis consistent with CD;
aged 16-75;
patients in remission (CDAI < 150 and CRP < 5mg/l, or Faecal calprotectin < 50μg/g, or no ulcer under endoscopy);
patients with frequent disease recurrences (≥2) in the past years;
Disqualifiers
patients who are recently pregnant or in pregnancy or lactation;
patients with serious organic diseases;
patients diagnosed as psychosis;
patients who suffer from multiple diseases and need to take other drugs for a long time, and may affect the observation of the efficacy of this trial;
Trial design
Treatments tested in this trial
- "Harmonizing Shaoyang, nourishing spleen and kidney with warmth" Acupuncture Group
- "Nourishing spleen and kidney with warmth" Acupuncture Group
Treatment groups
106 Participants
are divided into 2 treatment groupsSponsors and collaborators
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Lead sponsor
Ruijin Hospital
Collaborator
Source ClinicalTrials.gov